Mink Therapeutics (NasdaqCM:INKT) Q4 2025 Earnings call March 31, 2026 08:30 AM ET Company ParticipantsEmily Bodnar - VP of Equity ResearchJennifer Buell - President and CEOMayank Mamtani - Senior Managing Director and Group Head of Healthcare ResearchMelissa Orilall - Principal Financial OfficerStephanie Perna-Nacar - Chief Communications OfficerOperatorGood morning, and welcome to MiNK Therapeutics' fourth quarter and year-end 2025 financial results conference call. All participants will be in a listen-on ...